REACH規制後の赤色タトゥーアレルギー: 継続的な問題
1"Tattoo poli" Clinic, Department of Dermatology, Alrijne Hospital, Leiden.
Dermatology reports
|September 2, 2025
まとめ
赤色タトゥーインクに対するアレルギーは,新しいEU規制にもかかわらず,公衆衛生に危険性があります. 化学物質の登録,評価,認可および制限 (REACH) 規制の現在の規則は,消費者をより良く保護するために改定する必要があります.
科学分野:
- 皮膚科
- 公衆衛生
- 規制科学
背景:
- 赤色のタトゥーインクに対するアレルギー反応は依然として一般的です.
- 新しい欧州連合 (EU) の規制は,タトゥー・ピグメントアレルギーの問題を完全に解決していない.
- 赤色タトゥーピグメントは,臨床環境で頻繁に遭遇します.
研究 の 目的:
- タトゥーインクの安全性に関する現在のEU規制の有効性を評価する.
- タトゥーインクに関する化学品の登録,評価,認可,制限 (REACH) 規則の適用範囲と執行を疑問視する.
- 消費者をタトゥーアレルゲンから守るための 緊急の規制改正の必要性を強調する
主な方法:
- タトゥーのインク反応の臨床観察
- 既存のEU化学物質規制 (REACH) の分析
- 消費者保護への規制影響の評価
主要な成果:
- 赤色タトゥーインクアレルギーは 臨床的に有意な割合で発生しています
- 既存の規制は,タトゥーインクで知られているアレルゲンに消費者が曝されるのを防ぐには不十分である.
- REACHの有効性,適用範囲,執行は疑問視されている.
結論:
- 現在,EUの規制によるタトゥーインクの制限は不十分です.
- 赤いタトゥーインクのアレルゲンに対する消費者保護を強化するために,緊急に規制の改正が必要である.
- タトゥーに関連するアレルギーの流行が 公衆の健康を脅かしています
関連する概念動画
Allergic Reactions
28.5K
Overview
28.5K
Allergic Drug Reactions
972
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
972
Toxic Reactions: Overview
1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
Pharmacovigilance
983
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
983
Cross-reactivity
31.5K
Overview
31.5K
Hypersensitivities
1.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.0K


